Our previous work showed that Gal-9 is associated with a poor prognosis in patients with NPC and induces tumor immune tolerance by mediating the expansion of myeloid-derived suppressor cells in a manner dependent on stimulator of interferon gene (STING) signaling (11). This evidence concerns the gene LGALS9 and neoplasm.